Log In
Print
BCIQ
Print
Print this Print this
 

Nesina, alogliptin (SYR-322)

Also known as: formerly TAK-322

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOral dipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase-4 (DPP-4) inhibitor
Latest Stage of DevelopmentMarketed
IndicationDiabetes
Partner

Furiex Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today